The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome
about
Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial HypertensionCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesSodium-retaining effect of insulin in diabetesModulation of glucose metabolism by the renin-angiotensin-aldosterone systemThe role of metabolic syndrome in heart failureSympathoexcitation and arterial hypertension associated with obstructive sleep apnea and cyclic intermittent hypoxiaAntioxidant resveratrol restores renal sodium transport regulation in SHRTargeted deletion of murine CEACAM 1 activates PI3K-Akt signaling and contributes to the expression of (Pro)renin receptor via CREB family and NF-κB transcription factors.The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptorsCancer Stem Cells in Moderately Differentiated Lip Squamous Cell Carcinoma Express Components of the Renin-Angiotensin SystemRisk Assessment of Hepatocellular Carcinoma in General Population by Liver Stiffness in Combination with Controlled Attenuation Parameter using Transient Elastography: A Cross Sectional Study.Hyperglycemia and blood pressure treatment goal: a cross sectional survey of 18350 patients with type 2 diabetes in 77 tertiary hospitals in China.Metabolic syndrome in hypertensive patients: An unholy alliance.Telmisartan improves insulin resistance of skeletal muscle through peroxisome proliferator-activated receptor-δ activation.Prenatal exposure to lipopolysaccharide results in local RAS activation in the adipose tissue of rat offspringAngiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.Milk-derived tripeptides IPP (Ile-Pro-Pro) and VPP (Val-Pro-Pro) promote adipocyte differentiation and inhibit inflammation in 3T3-F442A cellsObesity-induced hypertension: interaction of neurohumoral and renal mechanismsSkeletal muscle insulin resistance in salt-sensitive hypertension: role of angiotensin II activation of NFκB.Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen.Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.Asiatic acid attenuates renin-angiotensin system activation and improves vascular function in high-carbohydrate, high-fat diet fed rats.Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome.Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male miceIs visceral adiposity a modifier for the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes?Free Fatty Acids Activate Renin-Angiotensin System in 3T3-L1 Adipocytes through Nuclear Factor-kappa B PathwayThe renin angiotensin aldosterone system and insulin resistance in humans.Perinatal taurine exposure affects adult arterial pressure control.Sympathoexcitation associated with Renin-Angiotensin system in metabolic syndrome.Cardiovascular risk escalation with caloric excess: a prospective demonstration of the mechanics in healthy adultsAngiotensin-Converting Enzyme 2 Deficiency Aggravates Glucose Intolerance via Impairment of Islet Microvascular Density in Mice with High-Fat Diet.Angiotensin-converting enzyme inhibition reduces food intake and weight gain and improves glucose tolerance in melanocortin-4 receptor deficient female rats.The Role of Aldosterone in Obesity-Related Hypertension.Mitochondrial uncoupling proteins regulate angiotensin-converting enzyme expression: crosstalk between cellular and endocrine metabolic regulators suggested by RNA interference and genetic studiesDeletion of angiotensin II type 2 receptor accelerates adipogenesis in murine mesenchymal stem cells via Wnt10b/beta-catenin signalingUse of total cerebral blood flow as an imaging biomarker of known cardiovascular risksToll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension.Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndromeInsulin resistance and heart failure: molecular mechanismsInsights into the activity, differential expression, mutual regulation, and functions of matrix metalloproteinases and a disintegrin and metalloproteinases in hypertension and cardiac disease.
P2860
Q26747017-C281C080-D095-422E-8F76-FE59C54A908DQ27002459-9A489B71-AFCA-4DF4-9170-7DE140E97897Q27015001-009EE20A-43B0-4885-82B1-C60BC792AAC9Q27026157-51E59D50-F79A-4F89-B2D6-75CF375DE3E1Q28085668-DC135D11-EC1B-41C8-80A0-266B5C9700FCQ28088502-38239CF5-1C1C-4FEC-87E6-516D4974B949Q28395907-862895FF-F4FA-4D7B-B6F8-3342A5AD34A0Q30411540-142726B1-3A00-4B4A-B4F5-BE761E61481FQ30486707-345F445F-8566-4C6E-9A14-B1CE9171D7AEQ33766069-B0583706-E53E-47DC-BFB6-36F217D942A0Q33885985-3627FDCF-24BF-4C3D-A138-90E645A2DF49Q34046606-16AE4A5D-5CCF-4184-BEF8-6EA5EF743EDEQ34251860-50DF8F3B-46DF-4143-9B89-05BC879070D3Q34317509-16D7D45A-139B-4CC5-9AC0-F76C1AC80666Q34434707-D05C66F4-DC37-49C0-B837-B58BDB5C3456Q34796700-4F8EA7DA-F274-4764-A016-EF1DDE4099C6Q35121959-C5385407-18F2-4576-BF85-E7806FF8F635Q35186358-64631EEC-3D6C-45C3-9AD6-99C14BD14D55Q35576849-D8E78216-0212-4FFF-A717-FFFB7150386FQ35624869-BDA9F05C-6BDF-4FC0-848A-DEF48F2D14C3Q35958750-88249C5D-4326-4BEA-8439-D8930897712AQ36001054-A141242A-1038-4B52-B472-44B3E8C49F90Q36329909-BF9139BC-4B65-42DE-ACA7-4BFB82C4D107Q36453507-1546C62E-0234-439F-B67F-359973CCA5C1Q36485459-100B3A2D-333D-4C3C-8DDC-8CE4F1B53F2BQ36529745-6B4ACBFA-A7EB-4AE7-911A-57AC1E47D24AQ36550987-D62D5465-D765-4348-BCB6-54537D578B74Q36592587-45B962BC-3274-43B8-9B92-289A1F081101Q36651383-C3BD2A14-BE56-4011-84E9-0E2AAD745075Q36687279-B6BCEB90-05F2-4B27-A518-ED0BE33DA645Q36825669-8DC11687-1C28-477C-BAAE-98874E9C1894Q36927003-E3AADE56-8361-46BE-AD6A-D2142CB5BE1CQ36950174-D467F858-AEB9-4E86-AFFF-7AE0C300C79FQ37024893-2C044C35-F199-41D9-A297-9A7565B0DF9CQ37136352-F1603816-FE00-446E-A19E-C6CC60D8B239Q37254592-64CD4C94-26EE-48C2-A407-D7FDB513FE19Q37575843-679CDFBF-8C3A-4563-BDB0-96F60E616B67Q37643052-DE535F4F-B8CD-43FB-B8FD-670351A7FE30Q38045550-CA77F8C9-2C8E-4512-ABC8-9C840038F66CQ38061567-D9B6DD44-FB6E-4A1E-A5CE-393DC9C0026F
P2860
The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The renin-angiotensin system: ...... sion of the metabolic syndrome
@ast
The renin-angiotensin system: ...... sion of the metabolic syndrome
@en
type
label
The renin-angiotensin system: ...... sion of the metabolic syndrome
@ast
The renin-angiotensin system: ...... sion of the metabolic syndrome
@en
prefLabel
The renin-angiotensin system: ...... sion of the metabolic syndrome
@ast
The renin-angiotensin system: ...... sion of the metabolic syndrome
@en
P2093
P2860
P1476
The renin-angiotensin system: ...... sion of the metabolic syndrome
@en
P2093
Frederique Yiannikouris
Kelly Putnam
Lisa A Cassis
Robin Shoemaker
P2860
P304
P356
10.1152/AJPHEART.00796.2011
P577
2012-01-06T00:00:00Z